Smith Group Asset Management’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | – | Sell |
-9,438
| Closed | -$210K | – | 483 |
|
|
2016
Q2 | $210K | Buy |
9,438
+3,691
| +64% | +$82.1K | 0.01% | 245 |
|
|
2016
Q1 | $120K | Buy |
5,747
+1,361
| +31% | +$28.4K | ﹤0.01% | 261 |
|
|
2015
Q4 | $133K | Buy |
4,386
+839
| +24% | +$25.4K | ﹤0.01% | 270 |
|
|
2015
Q3 | $88K | Buy |
3,547
+498
| +16% | +$12.4K | ﹤0.01% | 274 |
|
|
2015
Q2 | $98K | Buy |
3,049
+259
| +9% | +$8.33K | ﹤0.01% | 247 |
|
|
2015
Q1 | $100K | Buy |
+2,790
| New | +$100K | ﹤0.01% | 295 |
|